Bro¨ring et al.
undertaken on a Agilent 6850 Network GC using helium as carrier
gas, a Agilent HP-1 column, and a FID for quantitative detection.
123.8, 125.9, 129.6, 130.1, 130.9, 131.2, 133.7, 134.7, 146.7, 149.3,
149.5, 153.1, 170.9; MS (EI, 70 eV): m/z ) 332 (M+•); HRMS
(EI): Calcd for C19H16N4S: 332.1096; found: 332.1089.
Preparation of 1-Arylimino-3-iminoisoindolines 9-11: General
Procedure. 1,3-Diiminoisoindoline 5 (0.72 g, 4.95 mmol) and the
aniline derivative 6, 7, or 8 (1 equiv) are suspended in ethanol (10
mL) and heated to reflux for 6 (9) or 18 h (10, 11), respectively.
The solvent is then removed in vacuo, and the residue is subjected
to silica chromatography. In a first fraction, unreacted aniline
derivative is eluted with dichloromethane. After changing the
solvent to ethyl acetate the product is obtained in the second,
yellowish fraction.
1-Phenylimino-3-iminoisoindoline (9). Obtained (227 mg, 21%)
as a yellow solid; 1H NMR (300 MHz, CD2Cl2): δ ) 4.61 (s br, 2
H, NH2), 7.00-7.03 (m, 2 H, 2-CHPh), 7.15-7.21 (m, 1 H, 4-CHPh),
7.35-7.41 (m, 2 H, 3-CHPh), 7.48-7.52 (m, 1 H, R-CH), 7.55-7.66
(m, 2 H, ꢀ′-CH, ꢀ-CH), 7.90-7.96 (m, 1 H, R′-CH); 13C NMR
(75 MHz, CD2Cl2): δ ) 120.2, 121.9, 122.4, 123.5, 129.0, 130.9,
131.9, 132.5, 133.2, 137.4, 150.9, 157.1; MS (EI, 70 eV): m/z )
221 (M+•); HRMS (EI): Calcd for C14H11N3: 221.0953; found:
221.0955.
1-(6-Methylpyridylimino)-3-(1-iodophenylimino)isoindoline (16). Ob-
tained (175 mg, 40%) after chromatography on silica with pentane/
ethyl acetate (5:1) as a yellow solid; 1H NMR (200 MHz, CDCl3):
δ ) 2.18 (s, 3 H, Me), 6.84-6.95 (m, 2 H, 5-CHPh, 5-CHPy),
7.15-7.26 (m, 2 H, 3-CHPh, 3-CHPy), 6.44 (td, J ) 7.9 Hz, J )
1.5 Hz, 1 H, 4-CHPh), 7.61 (t, J ) 7.7, 1 H, 4-CHPy), 7.67-7.74
(m, 2 H, ꢀ-CH, ꢀ′-CH), 7.98 (dd, J ) 6.6 Hz, J ) 1.3 Hz, 1 H,
6-CHPh), 8.02-8.21 (m, 2 H, R-CH, R′-CH), 12.31 (br.s, 1 H, NH);
13C NMR (50 MHz, CDCl3): δ ) 24.3, 92.5, 119.8, 120.5, 120.8,
122.7, 122.9, 125.8, 129.5, 132.0, 133.9, 136.7, 138.6, 139.7, 151.0,
152.5, 153.9, 156.1, 160.1; UV-vis (CH2Cl2): λmax ) 231, 273,
349 nm; MS (EI, 70 eV): m/z ) 438 (M+•); HRMS (EI): Calcd for
C20H15IN4: 438.0341; found: 438.0349.
Preparation of Palladium(II) Complexes of 1-Hetarylimino-3-
aryliminoisoindolines 17-19: General procedure. 1-Hetarylimino-
3-aryliminoisoindoline 14, 15, or 16 (1 equiv, 0.4 mmol) and
Pd(OAc)2 (1 equiv, 0.4 mmol) are suspended in methanol (8 mL)
at ambient temperature and stirred for 16 h. After removal of all
volatiles the residue is purified as indicated below.
1-(2-Tolylimino)-3-iminoisoindoline (10). Obtained (218 mg,
1
19%) as a yellow solid; H NMR (300 MHz, CD2Cl2): δ ) 2.11
(s, 3 H, CH3), 6.86-6.90 (m, 1 H, CHPh), 7.13-7.30 (m, 3 H,
CHPh), 7.37-7.40 (m, 1 H, R-CH), 7.54-7.66 (m, 2 H, ꢀ-CH),
7.95-7.99 (m, 1 H, R-CH), no signal for NH protons observed;
13C NMR (75 MHz, CD2Cl2): δ ) 17.7, 119.8, 121.2, 122.4, 122.9,
126.3, 129.5, 130.2, 130.6, 131.7, 133.8, 137.8, 151.0, 160.1, 168.2;
MS (EI, 70 eV): m/z ) 235 (M+•); HRMS (EI): Calcd for C15H13N3:
235.1109; found: 235.1116.
Hydrogen{acetato-[1-(6-methylpyridylimino)-3-phenyliminoisoin-
dolinato]palladate(II)} H[(phpi)Pd(OAc)] (17). Obtained from 14 (19
mg, 10%) after fractionating recrystallization from n-hexane/
chloroform (1:1) as a bright red solid; 1H NMR (400 MHz,
[D6]DMSO): δ ) 1.90 (s, 3 H, OAc), 2.93 (s, 3 H, -CH3),
6.95-6.99 (m, 1 H, CHPh), 7.14-7.19 (m, 2 H, CHPy, CHPh),
7.29-7.34 (m, 2 H, CHPy, CHPh), 7.58-7.62 (m, 2 H, ꢀ,ꢀ′-CH),
7.66 (d, J ) 7.2 Hz, 1 H, CHPh), 7.87 (t, J ) 7.7 Hz, 1 H, 4-CHPy),
7.92-7.99 (m, 2 H, R′-CH), 11.93 (br.s, 1 H, NH); 13C NMR
(HMQC, 400 MHz, [D6]DMSO): δ ) 20.4, 26.0, 120.5, 120.8,
121.5, 123.5, 125.0, 128.6, 129.6, 131.0, 132.8, 138.6 (no quar-
1-(1-Iodophenylimino)-3-iminoisoindoline (11). Obtained (610
1
mg, 36%) as a yellow solid; H NMR (300 MHz, CDCl3): δ )
5.75 (br.s, 2 H, NH2), 6.92 (dt, J ) 7.8 Hz, J ) 1.3 Hz, 1 H, CHPh),
7.01 (dd, J ) 7.9 Hz, J ) 1.6 Hz, 1 H, CHPh), 7.33-7.40 (m, 2 H,
R-CH, CHPh), 7.53-7.68 (m, 2 H, ꢀ′-CH, ꢀ-CH), 7.91 (dd, J )
7.9 Hz, J ) 1.3 Hz, 1 H, CHPh), 8.02 (d, 1 H, R′-CH); 13C NMR
(75 MHz, CDCl3): δ ) 121.7, 122.6, 123.2, 124.3, 128.4, 130.7,
131.7, 132.2, 132.8, 136.6, 138.6, 152.6; MS (EI, 70 eV): m/z )
347 (M+•); HRMS (EI): Calcd for C14H11IN3: 346.9919; found:
346.9914.
ternary carbon centers were observed); UV-vis (CH2Cl2): λmax
)
232, 337, 448 nm; MS (APCI): m/z ) 416 ([M-HOAc]-); HRMS
(APCI): Calcd for C20H14N4Pd: 416.0248; found: 416.0248. CHN
determinations did not result in reproducible data due to varying
amounts of cocrystallized 17′.
Pyridin-[1-(4-methylthiazolylimino)-3-(2-tolylimino)isoindolinato]-
palladium(II) [(2-tolti)Pd(py)] (18). Obtained from cyclopalladated
15 by recrystallization from pyridine/n-hexane as a reddish-brown
solid (91%); 1H NMR (400 MHz, CD2Cl2/C5D5N): δ ) 1.09 (s, 3
H, Me), 2.79 (s, 3H, Me), 5.81 (d, 1 H, J ) 7.8 Hz, CHPh), 6.40 (s,
1 H, CHTh), 6.60 (t, 1 H, J ) 7.5 Hz, CHPh), 7.06 (d, 1 H, J ) 7.0
Hz, CHPh), 7.35-7.41 (m, 1 H, ꢀ-CH), 7.40-7.50 (m, 1 H, ꢀ-CH),
7.97 (d, 1 H, J ) 7.5 Hz, R-CH), 8.11 (d, 1 H, J ) 7.3 H, R-CH);
13C NMR (100 MHz, CD2Cl2/C5D5N): δ ) 17.0, 19.7, 20.8, 110.1,
121.1, 121.4, 124.0, 126.6, 128.9, 130.0, 133.1, 135.7, 138.6, 139.0,
141.6, 146.3, 149.0, 155.8, 171.4, 172.8; UV-vis (CH2Cl2): λmax
) 237, 440 nm; MS (ESI, CH3CN): m/z ) 478 ([M - py + CH3CN
+ H]+); HRMS (ESI): Calcd for C21H18N5PdS ([M - py + CH3CN
+ H]+): 478.0312; found: 478.0319; CHN analysis: Calcd for
C24H19N5PdS C 55.87, H 3.71, N 13.57; found C 55.74, H 3.55, N
13.27.
Preparation of 1-Hetarylimino-3-aryliminoisoindolines 14-16:
General Procedure. 1-Arylimino-3-iminoisoindoline 9, 10, or 11 (1
equiv, 1.0 mmol) and heterocycle 12 or 13 (1 equiv, 1.0 mmol)
are suspended in n-butanol (10 mL) and heated to reflux for 7 h.
After removal of all volatiles, the residue is purified by column
chromatography as indicated below.
1-(6-Methylpyridylimino)-3-phenyliminoisoindoline (14). Obtained
(194 mg, 88%) after chromatography on silica with pentane/ethyl
acetate (3:1) as a yellow solid; 1H NMR (300 MHz, CD2Cl2): δ )
2.16 (s, 3 H, Me), 6.85 (d, J ) 7.3 Hz, 1 H, 5-CHPy), 7.15-7.24
(m, 4 H, 4 × CHPh), 7.41-7.48 (m, 2 H, 3-CHPh), 7.56-7.63 (m,
1 H, 4-CHPy), 7.64-7.78 (m, 2 H, ꢀ-CH, ꢀ′-CH), 7.95-8.05 (m,
2 H, R-CH, R′-CH), 12.28 (br.s, 1 H, NH); 13C NMR (75 MHz,
CD2Cl2): δ ) 120.2, 121.9, 122.4, 123.5, 129.0, 130.9, 131.9, 132.5,
133.2, 137.4, 150.9, 157.1; MS (EI, 70 eV): m/z ) 221 (M+•);
HRMS (EI): Calcd for C14H11N3: 221.0953; found: 221.0955.
1-(4-Methylthiazolylimino)-3-(2-tolylimino)isoindoline (15). Ob-
tained (120 mg, 36%) after chromatography on silica with pentane/
ethyl acetate (6:1) as a yellow solid; 1H NMR (300 MHz, CD2Cl2):
δ ) 2.15 (s, 3 H, Me), 2.26 (s, 3 H, Me), 6.60 (s, 1H, CHTh),
7.01-7.07 (m, 1 H, CHPh), 7.09-7.18 (m, 1 H, CHPh), 7.25-7.33
(m, 2 H, CHPh), 7.61-7.72 (m, 2 H, ꢀ-CH), 7.94-7.96 (m, 1 H,
R-CH), 8.05-8.08 (m, 1 H, R-CH), 11.65 (br.s, 1 H, NH); 13C
NMR (75 MHz, CD2Cl2): δ ) 16.2, 16.8, 110.1, 118.9, 121.8,
Hydrogen{acetato-[1-(6-methylpyridylimino)-3-(1-iodophenylimi-
no)isoindolinato]palladate(II)} H[(2-Iphpi)Pd(OAc)] (19). Obtained
from 16 (99 mg, 41%) after extraction in toluene, evaporation of
the solvent and recrystallization from dichloromethane/n-hexane
1
as a bright red solid; H NMR (400 MHz, [D6]DMSO): δ ) 1.88
(s, 3 H, OAc), 2.73 (s, 3 H, -CH3), 6.69 (t, J ) 7.6 Hz, 1 H,
4-CHPh), 7.21 (d, J ) 7.3 Hz, 1 H, 3-CHPy), 7.36 (d, J ) 7.8 Hz,
1 H, 5-CHPy), 7.60-7.67 (m, 2 H, ꢀ′-CH, ꢀ-CH), 7.67-7.71 (m,
1 H, CHPh), 7.80 (d, J ) 7.3 Hz, 1 H, CHPh), 7.90 (t, J ) 7.6 Hz,
6406 Inorganic Chemistry, Vol. 47, No. 14, 2008